“We have rejuvenated mice with anticancer treatments”: an advance that relaunches the dream of lengthening human life

The quest for human longevity has fascinated researchers for decades. Additionally, Similarly, Today, the emphasis is on advances that could push the limits of our lifespan. However, A recent study by the Max-Planck Institute for Biology of Aging in Cologne reveals that two drugs. Meanwhile, rapamycin and trametinib, could prolong the life of mice significantly. Moreover, These promising discoveries open up fascinating perspectives for aging science. Moreover, geroprotective medicine, although their human application “we have rejuvenated mice anticancer remains to be explored.

The ingenious association of rapamycin. In addition, trametinib – "we have rejuvenated mice anticancer

The combination of rapamycin and trametinib was highlighted by a team of researchers for its potential to prolong the life of mice. However, Rapamycin, known for its immunosuppressive properties, is commonly used to prevent rejection of transplanted organs. Meanwhile, Trametinib, on the other hand, is a targeted treatment for certain types of melanoma. Their association is an innovation, because it exploits distinct but complementary action mechanisms. These drugs, when administered together, show impressive synergy by increasing the longevity of mice up to 35% in females.

The results of this study are particularly remarkable. In addition to the extension of the lifespan. the treated mice have benefited from a significant improvement in their general state of health. The researchers observed a decrease in chronic inflammation. a slowdown in the development of tumors and an improvement in physical activity even “we have rejuvenated mice anticancer at an advanced age. These positive effects are explained by the joint action of drugs on the Ras/Insulin/Tor signaling pathway. essential to the regulation of metabolism and aging.

“His blood is resistant to 856 venom”: this man could make it possible to create a universal antidote against snake bites

Medicines’ action mechanisms – "we have rejuvenated mice anticancer

Rapamycin. trametinib act on key biological pathways to exercise their anti-aging effects. “we have rejuvenated mice anticancer Rapamycin targets MTOR protein, a central regulator of cell growth, metabolism and aging. Its inhibition makes it possible to slow down these processes, thus helping to prolong life. The Trametinib aims at the Ras/Mek/Erk path. involved in cell proliferation and inflammation, which gives it a role in the reduction of tumors and inflammation.

By combining these two drugs, the researchers have managed to create a synergistic effect that increases their effectiveness. This innovative approach could potentially be applied to other treatments. thus opening the way to a new generation of geroprotective therapies. However. the complexity of these interactions also highlights the need for additional research to fully understand their impact on human beings.

“5G penetrates the skin more than we thought”: this shock study relaunches the debate on powerful waves

Implications for aging research

The results of this study arouse great interest. in the development of new geroprotective drugs. If these discoveries can be translated into human treatments. they could transform our approach to aging, emphasizing the prevention and management of age -related diseases.

The RAS/Insulin/Tor signaling pathway, at the heart of these mechanisms, is a promising field of research. By targeting specific components of this path. researchers hope to develop treatments that not only prolong life, but also improve quality of life by “we have rejuvenated mice anticancer reducing chronic diseases associated with aging. However. it is crucial to proceed with caution, as the long -term effects of these drugs should be rigorously evaluated before any clinical application.

7,000 subscribers in 24 hours: this YouTube method explodes the counters without spending a penny

Future challenges. perspectives

Although the results obtained on the mice are promising, Many challenges remain to be met before being able to envisage a human application of these treatments. “we have rejuvenated mice anticancer The biological differences between species mean that what works in mice will not necessarily result in humans.

The next steps include rigorous clinical trials to determine the efficiency and safety of these drugs in humans. The potential of these treatments to transform anti-aging medicine is immense. but it is accompanied by an urgent need for in-depth research. What will be the impacts of these discoveries on our understanding of aging. our ability to prolong life in a healthy way?

The author relied on artificial intelligence to enrich this article.

Did you like it? 4.5/5 (30)